赛诺医疗 (688108)

Sino Medical Sciences Technology Inc.

KSH

Tags

New QFII HoldingsQFII Heavy PositionsSSE Innovation IndexSpecial Purpose Equipment ManufacturingSpecialized-Sophisticated-Distinctive-Innovative EnterprisesMedical DevicesPharmaceuticals and HealthcareFund Exclusive HoldingsForeign Capital BackgroundIncreasing Shareholder CountSTAR Market 200 IndexSTAR Market Growth IndexMargin Trading and Securities Lending医药生物

K-Line Chart

No K-line data available

Company NameSino Medical Sciences Technology Inc.
Listing Date2019-10-30
Issue Price6.99RMB
Registered Capital41604.810k RMB
Legal RepresentativeSun Jianhua
Registered Address2nd Floor, Zone B, TEDA Biomedical R&D Building, No. 5, 4th Street, Tianjin Development Area
IndustryMedical Devices
Main BusinessThe company focuses on the R&D, production, and sales of high-end interventional medical devices. Its product pipeline covers key interventional therapy areas such as cardiovascular, cerebrovascular, and structural heart disease. The company's self-developed and internationally patented BuMA biodegradable drug-eluting coronary stent system is its core product.
Company ProfileSino Medical Sciences Technology Inc. is an international company rooted in China and serving the global market, specializing in the R&D, production, and sales of high-end interventional medical devices. The company was founded in September 2007 in the Tianjin Economic-Technological Development Area, transformed into a joint-stock company in June 2018, with a registered capital of 360 million RMB. The company has subsidiaries in Beijing, Hong Kong, the United States, Japan, the Netherlands, and France, initially establishing an R&D, production, and operational system of international standards. Its business covers key interventional therapy areas such as cardiovascular, cerebrovascular, and structural heart disease. Adhering to independent innovation, strict quality control, and an internationalization strategy, the company is committed to advancing the development of China's interventional medical industry, building a 'Created in China' brand, and enhancing its global influence.

Stock Details

1. Key Indicators

  • Total Shares(W): 41604.80
  • Circulating A-Shares(W): 41604.80
  • Earnings Per Share(RMB): 0.0500
  • Net Assets Per Share(RMB): 2.1650
  • Operating Revenue(W RMB): 36385.45
  • Total Profit(W RMB): 3351.69
  • **Net Profit Attributable to Parent(W RMB) **: 2111.80
  • Net Profit Growth Rate(%): 293.46
  • Weighted Return on Equity(%): 2.3900
  • Operating Cash Flow Per Share(RMB): 0.2020
  • Undistributed Profit Per Share(RMB): -0.5098
  • Capital Reserve Per Share(RMB): 1.5909

2. Main Business

The main business covers:

  • R&D, production, and sales of high-end interventional medical devices

3. Company Basic Information

  • Company Name: Sinomed
  • Listing Date: Unknown
  • Industry: Unknown
  • Address: Unknown
  • Website: Unknown
  • Company Profile: Unknown

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
Data Not Available Data Not Available Data Not Available Data Not Available Data Not Available

5. Concept Sectors

  • Concept sector information not available

Remarks

  • Data update date: 2025-11-10
  • Data source: Public market information